Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
Clinical study seeks to examine new combination therapy for treating AML patients

Clinical study seeks to examine new combination therapy for treating AML patients

Notch activity of cells in tumor microenvironment can influence cancer metastases, study shows

Notch activity of cells in tumor microenvironment can influence cancer metastases, study shows

Study establishes ENL protein as potential drug target for acute myeloid leukemia

Study establishes ENL protein as potential drug target for acute myeloid leukemia

Researchers looking at ways to target lingering cancer stem cells that cause disease relapse

Researchers looking at ways to target lingering cancer stem cells that cause disease relapse

UNC Lineberger achieves major milestone with launch of cellular immunotherapy program

UNC Lineberger achieves major milestone with launch of cellular immunotherapy program

KRAS ‘imbalances’ that emerge over time may influence cancer treatment response

KRAS ‘imbalances’ that emerge over time may influence cancer treatment response

New molecule may inhibit growth of aggressive pediatric brain tumor

New molecule may inhibit growth of aggressive pediatric brain tumor

GUMC launches phase II clinical study to examine safety of cancer drug for Parkinson's disease

GUMC launches phase II clinical study to examine safety of cancer drug for Parkinson's disease

Fred Hutch scientists make important step in identifying specific T cells to fight against cancer

Fred Hutch scientists make important step in identifying specific T cells to fight against cancer

Novel antiviral drug can protect transplant patients against CMV infections

Novel antiviral drug can protect transplant patients against CMV infections

Scientists devise novel DNA vaccine approach against important cancer antigen targets

Scientists devise novel DNA vaccine approach against important cancer antigen targets

MSK researchers harness power of CRISPR/Cas9 to create more-potent CAR T cells

MSK researchers harness power of CRISPR/Cas9 to create more-potent CAR T cells

Research: Biomaterials that mimic bone marrow can alter blood cell development

Research: Biomaterials that mimic bone marrow can alter blood cell development

Essen Bioscience to Showcase IncuCyte® Live-cell Analysis System and Applications at AACR, Booth #1365

Essen Bioscience to Showcase IncuCyte® Live-cell Analysis System and Applications at AACR, Booth #1365

Researchers show how metabolism drives proliferation of tumor cells

Researchers show how metabolism drives proliferation of tumor cells

Targeting tumor suppressor protein could be effective treatment for some AML patients, study suggests

Targeting tumor suppressor protein could be effective treatment for some AML patients, study suggests

Young adults, adolescents with acute leukemia treated at specialized cancer centers have higher survival rates

Young adults, adolescents with acute leukemia treated at specialized cancer centers have higher survival rates

Researchers create novel model that reveals cellular, molecular events driving leukemia progression

Researchers create novel model that reveals cellular, molecular events driving leukemia progression

Doctors use targeted molecular drugs to treat fatal cancerous blood syndromes

Doctors use targeted molecular drugs to treat fatal cancerous blood syndromes

UMass Amherst study highlights unmet drug needs of patients with rare diseases

UMass Amherst study highlights unmet drug needs of patients with rare diseases

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.